-97%

est. 2Y upside i

Healthcare

A nonprofit stool bank enabling access to fecal transplants.

Rank

#3751

Sector

Biotechnology, Health Research

Est. Liquidity

~10Y

Data Quality

Data: Low

OpenBiome is a non-profit research foundation with no public valuation, no funding data, and declining revenue.

Last updated: July 4, 2026

Bull (10%)-80%

OpenBiome secures major grants or licenses its biorepository, stabilizing revenue at ~$1.8M; exit via acquisition by a pharma company at a nominal valuation.

Base (30%)-95%

Continued reliance on grants with slow decline; no exit; equity effectively worthless.

Bear (60%)-100%

Funding dries up, operations cease; equity fully wiped out.

Est. time to liquidity~10.0 years

Preference Stack Risk

low

Funding Intensity

0%

No preference stack exists as total funding is null.

Dilution Risk

low

No anticipated raises given non-profit status.

Secondary Liquidity

none

No secondary market exists for a non-profit foundation.

Questions to Ask at the Interview

Strategic questions based on OpenBiome's data — designed to show you've done your homework.

  • 1

    “What is the plan to generate sustainable revenue beyond grants?”

  • 2

    “How does the foundation intend to attract and retain talent without equity upside?”

  • 3

    “What is the expected timeline for liquidity or a potential acquisition?”

Community

Valuation Sentiment

Our model estimates -97% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.